Increased flow and shear stress enhance in vivo transforming growth factor-β1 after experimental arterial injury

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 4, 2000, Pages 923-930

  Song, Ruo H ^a   Kocharyan, Hrachya K ^a   Fortunato, John E ^a   Glagov, Seymour ^a   Bassiouny, Hisham S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Hemodynamics; Hyperplasia; Transforming growth factor 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SHEAR STRESS; VASCULAR SMOOTH MUSCLE;

EID: 0034042163     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.4.923     Document Type: Article

References (43)

1. Bassiouny HS, White S, Glagov S, Choi E, Giddens DP, Zarins CK. Anastomotic intimal hyperplasia: mechanical injury or flow induced. J Vasc Surg. 1992;5:708-717.
2. Zarins CK, Giddens DP, Bjaradaj BK, Sottiurai VS, Mabon RF, Glagov S. Carotid bifurcation atherosclerosis: quantitative correlation of plaque localization with flow velocity profiles and wall shear stress. Circ Res. 1983;53:502-514.
3. Ku DN, Giddens DP, Zarins CK, Glagov S. Pulsatile flow and atherosclerosis in the human carotid bifurcation: positive correlation between plaque localization and low and oscillating shear stress. Arteriosclerosis. 1985;5:293-302.
4. Glagov S, Zarins C, Giddens DP, Ku DN. Hemodynamics and atherosclerosis: insights and perspectives gained from studies of human arteries. Arch Pathol Lab Med. 1988;112:1018-1031.
5. Geary RL, Kohler TR, Vergel S, Kirkman TR, Clowes AW. Time course of flow-induced smooth muscle cell proliferation and intimal thickening in endomelialized baboon vascular grafts. Circ Res. 1994; 74:14-23.
6. Kohler TR, Jawien A. Flow affects development of intimal hyperplasia after arterial injury in rats. Arterioscler Thromb. 1992;12: 963-971.
7. Mattsson EJR, Kohler TR, Vergel SM, Clowes AW. Increased blood flow induces regression of intimal hyperplasia. Arterioscler Thromb Vasc Biol. 1997;17:2245-2249.
8. Bassiouny SH, Krievins D, Zarins CK, Abu-Hamad G, Glagov S. Distal arteriovenous fistula inhibits experimental anastomotic intimal thickening. Surg Forum. 1993;44:345-346.
9. Kohler TR, Kirkman TR, Kraiss LW, Zierler BK, Clowes AW. Increased blood flow inhibits neointimal hyperplasia in endothelialized vascular grafts. Circ Res. 1991;69:1557-1565.
10. Sterpetti AV, Cucina A, Fragale A, Lepidi S, Cavallaro A, D'Angelo LS. Shear stress influences the release of platelet derived growth factor and basic fibroblast growth factor by arterial smooth muscle cells. Eur J Vasc Surg. 1994;8:138-142.
11. Cucina A, Sterpetti AV, Borrelli V, Pagliei S, Cavallaro A, D'Angelo LS. Shear stress induces transforming growth factor-beta1 release by arterial endothelial cells. Surgery. 1998;123:212-217.
12. Diamond SL, Eskin SG, McIntire LV. Fluid flow stimulates tissue plasminogen activator secretion by cultured human endothelial cells. Science. 1989;243:1483-1485.
13. Diamond SL, Sharefkin JB, Dieffenbach C, Frasier-Scott K, McIntire LV, Eskin SG. Tissue plasminogen activator messenger RNA levels increase in cultured human endothelial cells exposed to laminar shear stress. J Cell Physiol. 1990;143:364-371.
14. Bassiouuny HS, Song RH, Hong XF, Singh A, Kocharyan H, Glagov S. Flow regulation of 72-kD collagenase IV (MMP-2) after experimental arterial injury. Circulation. 1998;98:157-163.
15. Koyama N, Koshikawa T, Morisaki N, Saito Y, Yoshida S. Bifunctional effects of transforming growth factor-β on migration of cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun. 1990; 169:725-729.
16. Halloran BG, Prorok GD, So BJ, Baxter BT. Transforming growth factor-β1 inhibits human arterial smooth muscle cell proliferation in a growth rate dependent manner. Am J Surg. 1995;170:193-197.
17. Mii S, Ware AJ, Kent CK. Transforming growth factor-beta inhibits human vascular smooth muscle cell growth and migration. Surgery. 1993;114:464-470.
18. Owens GK, Geisterfer AAT, Yang YW, Komoriya A. Transforming growth factor-β-induced growth inhibition and cellular hypertrophy in cultured vascular smooth muscle cells. J Cell Biol. 1988;107:771-780.
19. Morisaki N, Kawano M, Koyama N, Koshikawa T, Umemiya K, Saito Y, Yoshida S. Effects of transforming growth factor-β1 on growth of aortic smooth muscle cells: influence of interaction with growth factors, cell state, cell phenotype, and cycle. Atherosclerosis. 1991; 88:227-234.
20. McCaffrey TA, Consigli S, Du B, Falcone DJ, Sanbom TA, Spokolny AM, Bush HL Jr. Decreased type II/type I TGF-β receptor ratio in cells derived from human atherosclerotic lesions. J Clin Invest. 1995; 96:2667-2675.
21. Reddy KB, Howe PH. Transforming growth factor-β1-mediated inhibition of smooth muscle cell proliferation is associated with a late G1 cell cycle arrest. J Cell Physiol. 1993;156:48-55.
22. Sterpetti AV, Cucina A, Santoro L, Cardillo B, Cavallaro A. Modulation of arterial smooth muscle cell growth by hemodynamic forces. Eur J Vasc Surg. 1992;6:16-20.
23. Nabel EG, Shum L, Pompili VJ, Yang ZY, San H, Shu HB, Liptay S, Gold L, Gordon D, Derynck R, Nabel GJ. Direct transfer of transforming growth factor β1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci U S A. 1993;90:10759-10763.
24. Kanzaki T, Tamura K, Takahashi K, Saito Y, Akikusa B, Oohashi H, Kasayuki N, Ueba M, Morisaki N. In vivo effect of TGF-β1: enhanced intimal thickening by administration of TGF-β1 in rabbit arteries injured with a balloon catheter. ArteriosclerThromb Vasc Biol. 1995;15:1951-1957.
25. Zarins CK, Zatina MA, Glagov S. Correlation of postmortem angiography with pathologic anatomy: quantitation of atherosclerotic lesions. In: Bond MG, ed. Clinical Diagnosis of Atherosclerosis: Quantitative Methods of Evaluation. New York, NY: Springer-Verlag; 1986:283-306.
26. Ohno M, Cooke JP, Dzau VJ, Gibbons GH. Fluid shear stress induces endothelial transforming growth factor beta-1 transcription and production: modulation by potassium channel blockade. J Clin Invest. 1995;95:1363-1369.
27. Ueba H, Kawakami M, Yaginuma T. Shear stress as an inhibitor of vascular smooth muscle cell proliferation: role of transforming growth factor-β1 and tissue-type plasminogen activator. Arterioscler Thromb Vasc Biol. 1997;17:1512-1516.
28. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury, I: smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
29. Clowes AW, Schwartz SM. Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res. 1985;56:139-145.
30. Friedman MH, Hutchins GM, Bargeron CB, Deters OJ, Mark FF. Correlation between intimal thickness and fluid shear in human arteries. Atherosclerosis. 1981;39:425-436.
31. Binns RL, Ku DN, Stewart MT, Ansley JP, Coyle KA. Optimal graft diameter: effect of wall shear stress on vascular healing. J Vasc Surg. 1989;10:326-337.
32. Tohda K, Masuda H, Kawamura K, Shozawa T. Difference in dilatation between endothelium-preserved and -desquamated segments in the flow-loaded rat common carotid artery. Arterioscler Thromb. 1992;2:519-528.
33. Chen C, Coyle KA, Hughes JD, Lumsden AB, Ku DN. Reduced blood flow accelerates intimal hyperplasia in endarterectomized canine arteries. Cardiovasc Surg. 1997;5:161-168.
34. Roberts AB, Hline UI, Flanders KC, Sporn MB. Transforming growth factor-β: major role in regulation of extracellular matrix. Ann N Y Acad Sci. 1990;580:225-230.
35. Kerr LD, Miller DB, Matrisian LM. TGF-beta1 inhibition of transin/ stromelysin gene expression is mediated though a Fos binding sequence. Cell. 1990;61:267-278.
36. Matrisian LM, Ganser GL, Kerr LD, Pelton RW, Wood LD. Negative regulation of gene expression by TGF-beta. Mol Reprod Dev. 1992;32:111-120.
37. Zarins CK, Zatina MA, Giddens DP, Ku DN, Glagov S. Shear stress regulation of artery diameter in experimental atherogenesis. J Vasc Surg. 1987;5:413-420.
38. Langille BL, O'Donnell F. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science. 1986;231:405-407.
39. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SMF, Lawler J, Hynes RO, Boivin GP, Bouck N. Thrombospondin-1 is a major activator of TGF-β1 In vivo. Cell. 1998;93:1159-1170.
40. Resnick N, Collins T, Atkinson W, Bonthron DT, Dewey CF Jr, Gimbrone MA Jr. Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear-stress-responsive element. Proc Natl Acad Sci U S A. 1993;90:4591-4595.
41. Resnick N, Gimbrone MA Jr. Hemodynamic forces are complex regulators of endothelial gene expression. FASEB J. 1995;9:874-882.
42. Topper JN, Cai J, Qiu Y, Anderson KR, Xu YY, Deeds JD, Feeley R, Gimeno CJ, Woolf EA, Tayber O, Mays GG, Sampson BA, Schoen FJ, Gimbrone MA Jr, Falb D. Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc Natl Acad Sci U S A. 1997;94:9314-9319.
43. Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy MA. Production of transforming growth factor β1 during repair of arterial injury. J Clin Invest. 1991;88:904-910.